DK2250190T3 - Optimerede adhæsinfragmenter og tilsvarende nanopartikler, - Google Patents
Optimerede adhæsinfragmenter og tilsvarende nanopartikler,Info
- Publication number
- DK2250190T3 DK2250190T3 DK08784517.8T DK08784517T DK2250190T3 DK 2250190 T3 DK2250190 T3 DK 2250190T3 DK 08784517 T DK08784517 T DK 08784517T DK 2250190 T3 DK2250190 T3 DK 2250190T3
- Authority
- DK
- Denmark
- Prior art keywords
- nanoparticles
- corresponding nanoparticles
- optimized adhesion
- optimized
- fragments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08003845 | 2008-02-29 | ||
PCT/EP2008/004867 WO2009106102A1 (de) | 2008-02-29 | 2008-06-17 | Optimierte adhäsin-fragmente und entsprechende nanopartikel |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2250190T3 true DK2250190T3 (da) | 2012-07-16 |
Family
ID=39967419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08784517.8T DK2250190T3 (da) | 2008-02-29 | 2008-06-17 | Optimerede adhæsinfragmenter og tilsvarende nanopartikler, |
Country Status (18)
Country | Link |
---|---|
US (1) | US8796200B2 (da) |
EP (1) | EP2250190B1 (da) |
JP (1) | JP5552437B2 (da) |
KR (1) | KR101557982B1 (da) |
CN (1) | CN101977925B (da) |
AT (1) | ATE552268T1 (da) |
AU (1) | AU2008351621B2 (da) |
BR (1) | BRPI0822328A2 (da) |
CA (1) | CA2716648A1 (da) |
DK (1) | DK2250190T3 (da) |
ES (1) | ES2392089T3 (da) |
HK (1) | HK1153211A1 (da) |
IL (1) | IL207839A0 (da) |
MX (1) | MX2010009526A (da) |
NZ (1) | NZ587438A (da) |
PL (1) | PL2250190T3 (da) |
RU (1) | RU2010139903A (da) |
WO (1) | WO2009106102A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041407B (zh) * | 2012-12-19 | 2015-02-18 | 深圳先进技术研究院 | 核-壳型纳米造影剂、其制备方法及应用 |
ES2639855T3 (es) | 2013-12-23 | 2017-10-30 | Exchange Imaging Technologies Gmbh | Nanopartícula conjugada a péptidos de unión a CD44 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9317423D0 (en) * | 1993-08-21 | 1993-10-06 | Imp Cancer Res Tech | Monoclonal antibodies |
US6179912B1 (en) * | 1999-12-20 | 2001-01-30 | Biocrystal Ltd. | Continuous flow process for production of semiconductor nanocrystals |
US20020168367A1 (en) * | 2000-04-28 | 2002-11-14 | Planet Biotechnology Incorporated | Novel immunoadhesins for treating and preventing viral and bacterial diseases |
US7205048B2 (en) | 2001-09-17 | 2007-04-17 | Invitrogen Corporation | Functionalized fluorescent nanocrystal compositions and methods of making |
WO2003030227A2 (en) * | 2001-10-02 | 2003-04-10 | Quantum Dot Corporation | Method of semiconductor nanoparticle synthesis |
CN1672052A (zh) | 2002-06-27 | 2005-09-21 | 佐治亚技术研究公司 | 纳米级光学荧光标记及其用途 |
WO2005001889A2 (en) | 2003-05-07 | 2005-01-06 | Indiana University Research & Technology Corporation | Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto |
DE502005005689D1 (de) | 2005-05-04 | 2008-11-27 | Signalomics Gmbh | Kompetitives n-Hybrid System |
EP1777292A1 (de) | 2005-10-19 | 2007-04-25 | Signalomics GmbH | Verfahren zum Erzeugen von genetischer Diversität in vivo |
ES2627998T3 (es) | 2005-11-16 | 2017-08-01 | Exchange Imaging Technologies Gmbh | Nanopartículas fluorescentes |
PT2124880T (pt) | 2006-12-18 | 2018-05-16 | Exchange Imaging Tech Gmbh | Nanopartículas fluorescentes |
WO2009045579A2 (en) * | 2007-06-14 | 2009-04-09 | The Regents Of The University Of California | Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics |
-
2008
- 2008-06-17 CA CA2716648A patent/CA2716648A1/en not_active Abandoned
- 2008-06-17 DK DK08784517.8T patent/DK2250190T3/da active
- 2008-06-17 WO PCT/EP2008/004867 patent/WO2009106102A1/de active Application Filing
- 2008-06-17 AU AU2008351621A patent/AU2008351621B2/en not_active Expired - Fee Related
- 2008-06-17 AT AT08784517T patent/ATE552268T1/de active
- 2008-06-17 RU RU2010139903/10A patent/RU2010139903A/ru not_active Application Discontinuation
- 2008-06-17 BR BRPI0822328-9A patent/BRPI0822328A2/pt not_active IP Right Cessation
- 2008-06-17 ES ES08784517T patent/ES2392089T3/es active Active
- 2008-06-17 KR KR1020107021444A patent/KR101557982B1/ko active IP Right Grant
- 2008-06-17 JP JP2010547961A patent/JP5552437B2/ja not_active Expired - Fee Related
- 2008-06-17 US US12/920,236 patent/US8796200B2/en not_active Expired - Fee Related
- 2008-06-17 EP EP08784517A patent/EP2250190B1/de not_active Not-in-force
- 2008-06-17 CN CN200880128223.9A patent/CN101977925B/zh not_active Expired - Fee Related
- 2008-06-17 NZ NZ587438A patent/NZ587438A/en not_active IP Right Cessation
- 2008-06-17 MX MX2010009526A patent/MX2010009526A/es active IP Right Grant
- 2008-06-17 PL PL08784517T patent/PL2250190T3/pl unknown
-
2010
- 2010-08-26 IL IL207839A patent/IL207839A0/en unknown
-
2011
- 2011-07-19 HK HK11107481.8A patent/HK1153211A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2008351621A1 (en) | 2009-09-03 |
AU2008351621B2 (en) | 2013-05-09 |
JP2011514890A (ja) | 2011-05-12 |
NZ587438A (en) | 2012-04-27 |
WO2009106102A1 (de) | 2009-09-03 |
US8796200B2 (en) | 2014-08-05 |
PL2250190T3 (pl) | 2012-11-30 |
KR101557982B1 (ko) | 2015-10-06 |
CA2716648A1 (en) | 2009-09-03 |
ATE552268T1 (de) | 2012-04-15 |
US20110110856A1 (en) | 2011-05-12 |
HK1153211A1 (en) | 2012-03-23 |
EP2250190B1 (de) | 2012-04-04 |
IL207839A0 (en) | 2010-12-30 |
ES2392089T3 (es) | 2012-12-04 |
RU2010139903A (ru) | 2012-04-10 |
MX2010009526A (es) | 2010-11-26 |
CN101977925B (zh) | 2014-11-05 |
CN101977925A (zh) | 2011-02-16 |
JP5552437B2 (ja) | 2014-07-16 |
EP2250190A1 (de) | 2010-11-17 |
KR20110007111A (ko) | 2011-01-21 |
BRPI0822328A2 (pt) | 2015-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX355181B (es) | Anticuerpos humanos contra el factor tisular. | |
MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
MA32190B1 (fr) | Anticorps dirigés contre l'angiopoïétine 1 et l'angiopoïétine 2 et leur utilisation | |
UA106194C2 (ru) | Диагностика и лечение рака с применением антитела к ereg | |
HK1153273A1 (en) | Cancer diagnosis based on levels of antibodies against globo h and its fragments globo h | |
MX2009012625A (es) | Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21. | |
WO2009083009A3 (en) | Monoclonal antibodies against cd32b | |
WO2010099161A8 (en) | Micrornas in never-smokers and related materials and methods | |
WO2008104543A3 (en) | Method for predicting the occurrence of metastasis in breast cancer patients | |
WO2012088290A3 (en) | Tri-variable domain binding proteins and uses thereof | |
BRPI0813364A2 (pt) | Métodos de diagnóstico e tratamento de câncer. | |
EA200970891A1 (ru) | Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы | |
WO2009092108A3 (en) | Biomarkers for the diagnosis and treatment of pancreatic cancer | |
NO20091181L (no) | Anti-C5AR-antistoffer med forbedrede egenskaper | |
EP2385114A4 (en) | CANCER TREATMENT DIAGNOSIS WITH ANTI-TM4SF20 ANTIBODY | |
WO2008060945A3 (en) | Diagnosis and treatment of breast cancer | |
BRPI0923652A2 (pt) | diagnóstico e tratamento de câncer usando anticorpo anti-lgr7 | |
WO2009105457A3 (en) | Slit2 cancer markers | |
EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
DK2250190T3 (da) | Optimerede adhæsinfragmenter og tilsvarende nanopartikler, | |
WO2009158729A3 (en) | Compounds and methods for diagnosis and treatment of chagas disease | |
WO2011031833A3 (en) | Human anti-cancer antibodies | |
EP2123676A4 (en) | DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-PRG-3 ANTIBODIES |